上顎洞癌に対する多剤併用選択的動注療法+放射線療法の検討

概要

論文の詳細を見る
We experienced 10 patients with maxillary sinus cancer who underwent selective intraarterial chemotherapy via superficial temporal artery and conventional concurrent radiotherapy from 2003 to 2010 at Yokosuka Kyosai Hospital. Under the T classification only 1 case was T2, and the other 9 cases were T4a. Between 2003 and 2007, 6 patients were given intraarterial chemotherapy with cisplatin (or nedaplatin) and 5-fluorouracil. After 2008, 4 patients were given intraarterial chemotherapy with docetaxel, cisplatin (or nedaplatin), and 5-fluorouracil. The CR rate of CRT was 80%. The 5-year overall survival rate was 66.7%, and the 5-year disease specific survival rate was 74.1%. This method demonstrated good efficacy in patients with locoregionally advanced maxillary sinus cancer.
耳鼻咽喉科臨床学会の論文
2012-10-01